Affordable Access

Access to the full text

Short-term results of early switch from Ranibizumab to Aflibercept in poor or non responder age related macular degeneration in clinical practice

Authors
  • de Sá Quirino-Makarczyk, Luciana1
  • Sainz Ugarte, Maria de Fátima2
  • Viana Vieira, Bruna2
  • Kniggendorf, Sérgio1
  • Saito Regatieri, Caio Vinicius3
  • 1 Department of Retina and Vitreous of Hospital Oftalmológico de Brasília, Brasília, Brazil , Brasília (Brazil)
  • 2 Hospital Oftalmológico de Brasília, Brasília, Brazil , Brasília (Brazil)
  • 3 Federal University of São Paulo (UNIFESP), São Paulo, Brazil , São Paulo (Brazil)
Type
Published Article
Journal
International Journal of Retina and Vitreous
Publisher
BioMed Central
Publication Date
May 14, 2020
Volume
6
Issue
1
Identifiers
DOI: 10.1186/s40942-020-00212-5
Source
Springer Nature
Keywords
License
Green

Abstract

BackgroundTo evaluate the change in best corrected visual acuity (VA) and central macular thickness (CMT) following treatment with intravitreal aflibercept (AFL) in patients poorly responders or non responders to ranibizumab (RBZ).MethodsCharts of patients injected with RBZ from January 2016 to December 2018 (548 cases) due to neovascular age-related macular degeneration (nAMD) were reviewed. Fifty-six cases met our criteria for poor responders to RBZ (CMT decreased between 5 and 15% over treatment) or for non responders to RBZ (CMT decreased less than 5% or increased over treatment).ResultsAfter the third AFL injection, CMT decreased from 384.38 ± 123.20 μm to 296.18 ± 70.52 μm in the non-responder group and from 320.00 ± 82.05 μm to 282.27 ± 56.86 μm in the poor responder group. Although decrease in macular thickness was overall achieved 3 months after switching to AFL, it was not translated in VA improvement.Conclusionsit was observed that nAMD patients classified as RBZ non-responders tend to respond better to AFL than RBZ poor-responders anatomically, without correspondent improvement in VA.

Report this publication

Statistics

Seen <100 times